PD153035 hydrochloride
SIGMA/SML0564 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 183322-45-4
Empirical Formula (Hill Notation): C16H14BrN3O2 · HCl
Molecular Weight: 396.67
MDL Number: MFCD01074805
Linear Formula: C16H14BrN3O2 · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C16H14BrN3O2.ClH/c1-21 |
| InChI key | ZJOKWAWPAPMNIM-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Cl.COc1cc2ncnc(Nc3cccc(Br |
| solubility | DMSO: 2 mg/mL, clear (warmed) |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | PD153035 is an EGFR tyrosine kinase inhibitor. |
| Biochem/physiol Actions: | PD153035 is apotent and selective ATP competitive inhibitor of the epidermal growth factor receptor tyrosine kinase EGFR. |
| Features and Benefits: | This compound is a featured product for Kinase Phosphatase Biology research. Click here to discover more featured Kinase Phosphatase Biology products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound is featured on the EGFR page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | ![]() GHS05,GHS06 |
| Signal word | Danger |
| Hazard statements | H301 - H315 - H318 - H335 |
| Precautionary statements | P280 - P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 + P310 |
| Hazard Codes | T |
| Risk Statements | 25-37/38-41 |
| Safety Statements | 26-39-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 51111800 |



